Lipopolysaccharide Nanosystems for the Enhancement of Oral Bioavailability
- 30 September 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in AAPS PharmSciTech
- Vol. 22 (7), 1-25
- https://doi.org/10.1208/s12249-021-02124-5
Abstract
Nanosystems that incorporate both polymers and lipids have garnered attention as emerging nanotechnology approach for oral drug delivery. These hybrid systems leverage on the combined properties of polymeric and lipid-based nanocarriers while eliminating their inherent limitations. In view of the safety-related benefits of naturally occurring polymers, we have focused on systems incorporating polysaccharides and derivatives into the hybrid structure. The aim of this review is to evaluate existing biopolymers with specific focus on lipopolysaccharide hybrid systems and their advancement toward enhancing oral drug delivery. Furthermore, we shall identify future research areas that require further exploration toward achieving an optimized hybrid system for easy translation into clinical use. In this review, we have appraised formulations that combined polysaccharides/derivatives with lipids in a single nanocarrier system. These formulations were grouped into lipid-core-polysaccharide-shell systems, polysaccharide-core-lipid-shell systems, self-emulsifying lipopolysaccharide hybrid systems, and hybrid lipopolysaccharide matrix systems. In these systems, we highlighted how the polysaccharide phase enhances the oral absorption of encapsulated bioactives with regard to their function and mechanism. The various lipopolysaccharide designs presented in this review demonstrated significant improvement in pharmacokinetics of bioactives. A multitude of studies found lipopolysaccharide hybrid systems as nascent nanoplatforms for the oral delivery of challenging bioactives due to features that favor gastrointestinal absorption and bioavailability improvement. With future research already geared toward product optimization and scaling up processes, as well as detailed pharmacological and toxicology pre-clinical testing, these versatile systems will have remarkable impact in clinical application. Graphical abstractKeywords
This publication has 119 references indexed in Scilit:
- Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral deliveryInternational Journal of Pharmaceutics, 2012
- Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriersAdvanced Drug Delivery Reviews, 2012
- Fate of polymeric nanocarriers for oral drug deliveryCurrent Opinion in Colloid & Interface Science, 2011
- Functional aliphatic polyesters for biomedical and pharmaceutical applicationsJournal of Controlled Release, 2011
- Effect of chitosan coating in overcoming the phagocytosis of insulin loaded solid lipid nanoparticles by mononuclear phagocyte systemCarbohydrate Polymers, 2011
- Controlled Release of Oral Tetrahydrocurcumin from a Novel Self-Emulsifying Floating Drug Delivery System (SEFDDS)AAPS PharmSciTech, 2010
- Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic deliveryNanomedicine: Nanotechnology, Biology and Medicine, 2009
- Preparation and Evaluation of Self-nanoemulsifying Tablets of CarvedilolAAPS PharmSciTech, 2009
- The Mucosa of the Small IntestineClinical Pharmacokinetics, 2002
- Current Concepts in Intestinal Peptide AbsorptionJournal of Peptide Science, 1996